Quick Answer
Vicapsys Life Sciences, Inc. reported Shares Outstanding of 32.07 million shares for fiscal year 2023.
Vicapsys Life Sciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2023 | 32.07M | +2.8% |
| 2022 | 31.19M | +57.9% |
| 2021 | 19.75M | +12.9% |
| 2020 | 17.48M | +0.0% |
| 2019 | 17.48M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | 32.37M | +0.9% | +0.9% |
| June 30, 2024 | 32.07M | +2.8% | +0.0% |
| March 31, 2024 | 32.07M | +2.8% | +0.0% |
| December 31, 2023 | 32.07M | +2.8% | +0.0% |
| September 30, 2023 | 32.07M | +2.8% | +2.8% |
| June 30, 2023 | 31.19M | +0.0% | +0.0% |
| March 31, 2023 | 31.19M | +0.0% | +0.0% |
| December 31, 2022 | 31.19M | +57.9% | +0.0% |
- Vicapsys Life Sciences, Inc. showed an increase of +2.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2023 period, Vicapsys Life Sciences, Inc.’s shares outstanding has grown by 83.4% (from 17.48 million shares to 32.07 million shares).
- The most recent figure is from Vicapsys Life Sciences, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on October 21, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: